Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Non-Current Deffered Revenue (2020 - 2025)

Historic Non-Current Deffered Revenue for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $16.9 million.

  • Sotera Health's Non-Current Deffered Revenue fell 584.41% to $16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year decrease of 584.41%. This contributed to the annual value of $16.8 million for FY2024, which is 1054.26% down from last year.
  • Per Sotera Health's latest filing, its Non-Current Deffered Revenue stood at $16.9 million for Q3 2025, which was down 584.41% from $17.4 million recorded in Q2 2025.
  • Sotera Health's 5-year Non-Current Deffered Revenue high stood at $21.6 million for Q2 2021, and its period low was $16.7 million during Q1 2025.
  • Moreover, its 5-year median value for Non-Current Deffered Revenue was $18.8 million (2022), whereas its average is $19.0 million.
  • Per our database at Business Quant, Sotera Health's Non-Current Deffered Revenue tumbled by 74.07% in 2023 and then plummeted by 1054.26% in 2024.
  • Quarter analysis of 5 years shows Sotera Health's Non-Current Deffered Revenue stood at $20.7 million in 2021, then fell by 8.88% to $18.9 million in 2022, then dropped by 0.74% to $18.8 million in 2023, then decreased by 10.54% to $16.8 million in 2024, then increased by 0.89% to $16.9 million in 2025.
  • Its Non-Current Deffered Revenue stands at $16.9 million for Q3 2025, versus $17.4 million for Q2 2025 and $16.7 million for Q1 2025.